NCT04989335 2023-11-28Bisantrene Combination for Resistant AMLSheba Medical CenterPhase 2 Unknown29 enrolled
NCT00838240 2012-07-20AML-14AEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 1/2 Unknown114 enrolled